Australia's largest stock trading and investment forum Australia's #1 stock forum

CHM

Click for more information

0.00%

1.4¢ chimeric therapeutics limited

Clinical Trials, page-14

First 14 Last

Share
Profile

Follow
dalts66

4,385 Posts.

2046

26/07/23

19:21

Post #: 68998555
Share

Originally posted by smashintins: ↑

Could really go either way. They could be trying to figure out what’s gone wrong or results are better than expected and they want time to write something to publish. I’d be annoyed if all the time and money that’s been deployed for the phase 1b was all for nothing, but then why would they bother if they weren’t seeing decent results? I dunno but could be an interesting end to the year.

Expand

And city of hope, where the trial has been run for the first 2 cohorts, gave ethics approval for the 1b trial. They wouldnt do that if they didnt see promise with the drug.

CHM Price at posting: 4.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

IMA

Issues emerging as Australian companies tackle critical minerals challenge

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

There are more pages in this discussion • 3 more messages in this thread...

First 14 Last

Add CHM (ASX) to my watchlist